ABCC7 p.Asp979Ala
[switch to full view]Comments [show]
None has been submitted yet.
PMID: 16442101
[PubMed]
Frelet A et al: "Insight in eukaryotic ABC transporter function by mutation analysis."
No.
Sentence
Comment
415
Clain et al. [201] showed that R347H was associated with mild defective ClÀ channel activity and that D979A defect led to misprocessing.
X
ABCC7 p.Asp979Ala 16442101:415:107
status: NEW
PMID: 10376575
[PubMed]
Mak V et al: "Proportion of cystic fibrosis gene mutations not detected by routine testing in men with obstructive azoospermia."
No.
Sentence
Comment
45
(%) Men With 2 Mutations ⌬F508/IVS8-5T 7 (11) ⌬F508/IVS8-5T 1 (10) ⌬F508/IVS8-5T 1 (1.8) ⌬F508/R117H 6 (9) W1282X/IVS8-5T 1 (1.8) ⌬F508/L206W 1 (1.6) G544S/IVS8-5T 1 (1.8) ⌬F508/M952T 1 (1.6) V754M/-741T→G 1 (1.8) ⌬F508/P67L 1 (1.6) R75Q/R258G 1 (1.8) ⌬F508/S549R 1 (1.6) R334W/R334W 1 (1.6) R117H/R117H 1 (1.6) R117H/IVS8-5T 1 (1.6) R347P/IVS8-5T 1 (1.6) N1303K/IVS8-5T 1 (1.6) 1677delTA/IVS8-5T 1 (1.6) R117L/IVS8-5T 1 (1.6) D979A/IVS8-5T 1 (1.6) IVS8-5T/IVS8-5T 1 (1.6) Men With 1 Mutation IVS8-5T/N 10 (16) ⌬F508/N 1 (10) IVS8-5T/N 9 (16) ⌬F508/N 1 (2) ⌬F508/N 6 (9) IVS8-5T/N 1 (10) ⌬F508/N 1 (1.8) G542X/N 1 (2) W1282X/N 2 (3) R75Q/N 1 (1.8) IVS8-5T/N 5 (10) L206W/N 1 (1.6) W1282X/N 1 (1.8) 4016insT/N 1 (1.6) R117H/N 1 (1.8) 2423delG/N 1 (1.8) Men With No Mutations 18 (28) 7 (70) 37 (66) 42 (86) *N indicates that no CFTR mutations or variants were detected.
X
ABCC7 p.Asp979Ala 10376575:45:490
status: NEW50 Of the 8 additional CFTR gene sequence alterations detected using extensive CFTR exon screening, 5 have been described rarely in the CF population (L206W [identified in 2 subjects], P67L, 1677delTA, R117L, and 4016insT).60 One mutation, D979A, was previously identified in a Vietnamese CBAVD patient.60 Interestingly, our CBAVD subject with D979A (also a carrier of IVS8-5T) was of Vietnamese descent as well.
X
ABCC7 p.Asp979Ala 10376575:50:237
status: NEWX
ABCC7 p.Asp979Ala 10376575:50:341
status: NEW58 (%) 31 Mutation panel† ⌬F508 23 (18) ⌬F508 2 (10) ⌬F508 2 (1.8) ⌬F508 1 (1) R117H 9 (7) W1282X 2 (1.8) G542X 1 (1) W1282X 2 (1.6) R117H 1 (0.9) R334W 2 (1.6) S549R 1 (0.8) R347P 1 (0.8) N1303K 1 (0.8) Extensive screen† ⌬F508 23 (18) ⌬F508 2 (10) ⌬F508 2 (1.8) ⌬F508 1Mutations included in R117H 9 (7) W1282X 2 (1.8) G542X 131 mutation panel W1282X 2 (1.6) R117H 1 (0.9) R334W 2 (1.6) S549R 1 (0.8) R347P 1 (0.8) N1303K 1 (0.8) L206W 2 (1.6)‡ R75Q 2 (1.8)‡Mutations not included in P67L 1 (0.8)‡ G544S 1 (0.9)‡31 mutation panel 1677delTA 1 (0.8)‡ 2423delG 1 (0.9)‡ R117L 1 (0.8)‡ V754M 1 (0.9)‡ 4016insT 1 (0.8)‡ -741T→G 1 (0.9)‡ D979A 1 (0.8)§ R258G 1 (0.9)§ M952T 1 (0.8)¶ IVS8-5T 25 (20)# 2 (10) 12 (11) 5 (5) Detectable mutations 72 (56)# 4 (20) 24 (21)# 7 (7) Detectable mutations missed by 31 mutation panel 33 (46) 2 (50) 19 (79) Detectable non-IVS8-5T mutations missed by 31 mutation panel 8 (17) 0 (0) 7 (58) *Percentages indicate allele frequency.
X
ABCC7 p.Asp979Ala 10376575:58:776
status: NEW86 As mentioned, D979A has been previously detected in a Vietnamese man with CBAVD,60 and interestingly, our CBAVD subject with D979A was also of Vietnamese descent.
X
ABCC7 p.Asp979Ala 10376575:86:14
status: NEWX
ABCC7 p.Asp979Ala 10376575:86:125
status: NEW
PMID: 11118444
[PubMed]
Clain J et al: "Two mild cystic fibrosis-associated mutations result in severe cystic fibrosis when combined in cis and reveal a residue important for cystic fibrosis transmembrane conductance regulator processing and function."
No.
Sentence
Comment
1
We investigated the structure-function relationships of a severe cystic fibrosis (CF)-associated double mutant (R347H-D979A) to evaluate the contribution of each mild mutation to the phenotype.
X
ABCC7 p.Asp979Ala 11118444:1:118
status: NEW3 Our data show that R347H is associated with mild defective Cl-channel activity and that the D979A defect leads to misprocessing.
X
ABCC7 p.Asp979Ala 11118444:3:92
status: NEW4 The mutant R347H-D979A combines both defects for a dramatic decrease in Cl- cur- rent.
X
ABCC7 p.Asp979Ala 11118444:4:17
status: NEW13 The recent discovery of severe CF associated with a ⌬F508/ R347H-D979A compound heterozygote genotype in two related patients suffering from pancreatic insufficiency and severe respiratory symptoms suggests that the R347H-D979A mutation has an important influence on CFTR processing and/or function (7).
X
ABCC7 p.Asp979Ala 11118444:13:72
status: NEWX
ABCC7 p.Asp979Ala 11118444:13:229
status: NEW14 At least four CF-associated mutations have been identified in isolation at position 347 (R347C, R347H, R347L, and R347P) and two at position 979 (D979A and D979V), suggesting that Arg-347 and Asp-979 are important for CFTR structure and/or function.
X
ABCC7 p.Asp979Ala 11118444:14:146
status: NEW15 The mutation D979A was found in isolation in a patient with a congenital bilateral absence of the vas deferens (8) and the R347H mutation in CF patients with pancreatic sufficiency, congenital bilateral absence of the vas deferens, and no or mild pulmonary symptoms (7).
X
ABCC7 p.Asp979Ala 11118444:15:13
status: NEW16 As the R347H mutation is mostly associated with mild CF, it was suggested that the D979A mutation has a significant effect on CFTR function when combined in cis with R347H.
X
ABCC7 p.Asp979Ala 11118444:16:83
status: NEW18 The mutations R347H and D979A replace positively charged (Arg) and negatively charged (Asp) residues with ones that are uncharged (His and Ala, respectively) at physiological pH.
X
ABCC7 p.Asp979Ala 11118444:18:24
status: NEW19 The present study investigates the structure-function relationships of the R347H-D979A double mutant, and as charged residues are involved in this complex genotype, single and double mutants with different charge combinations at residues 347 and 979 were constructed.
X
ABCC7 p.Asp979Ala 11118444:19:81
status: NEW21 Our data show that R347H is associated with defective chloride channel activity and that the D979A defect leads to misprocessing.
X
ABCC7 p.Asp979Ala 11118444:21:93
status: NEW22 The mutant R347H-D979A combines both defects for a dramatic decrease in Cl- current.
X
ABCC7 p.Asp979Ala 11118444:22:17
status: NEW58 We first studied the maturation of CFTR in HeLa cells to determine why patients with the R347H-D979A-CFTR allele suffered from severe CF.
X
ABCC7 p.Asp979Ala 11118444:58:95
status: NEW64 Immunoprecipitation experiments show that both wild-type and CF-associated mutants R347H, D979A, and R347H-D979A-CFTR cells produced mature, fully glycosylated protein (Fig. 1A; band C), whereas none of the mock-transfected cells produced CFTR (data not shown).
X
ABCC7 p.Asp979Ala 11118444:64:90
status: NEWX
ABCC7 p.Asp979Ala 11118444:64:107
status: NEW65 However, the D979A and R347H-D979A mutants produced significantly less band C (59 and 56% of the total CFTR; ratio C/(BϩC)) than wild-type and R347H-CFTR (92 and 91%; see Fig. 1B).
X
ABCC7 p.Asp979Ala 11118444:65:13
status: NEWX
ABCC7 p.Asp979Ala 11118444:65:29
status: NEW66 This indicates that the R347H-D979A mutation caused a misprocessing defect.
X
ABCC7 p.Asp979Ala 11118444:66:30
status: NEW67 The turnover of immature and mature forms of wild-type and R347H-D979A-CFTR proteins was further investigated by pulse-chase experiments (Fig. 1C).
X
ABCC7 p.Asp979Ala 11118444:67:65
status: NEW68 The kinetics of wild-type and R347H-D979A core-glycosylated and mature forms of CFTR were identical, whereas the efficiency of conversion to mature band C was lower for the mutant.
X
ABCC7 p.Asp979Ala 11118444:68:36
status: NEW69 Similar results were obtained with the D979A mutant (data not shown).
X
ABCC7 p.Asp979Ala 11118444:69:39
status: NEW71 Other mutants were generated to further characterize the D979A defect.
X
ABCC7 p.Asp979Ala 11118444:71:57
status: NEW82 C, pulse-chase experiments showing the turnover of the immature and mature forms of wild-type and R347H-D979A-CFTR (results are representative of two independent experiments).
X
ABCC7 p.Asp979Ala 11118444:82:104
status: NEW83 similar to D979A, whereas D979E permitted the complete maturation of the protein (Fig. 1B).
X
ABCC7 p.Asp979Ala 11118444:83:11
status: NEW84 Altogether, these results indicate that D979A is responsible for the defective processing of R347H-D979A-CFTR and that a negative charge at 979 residue is necessary for proper CFTR processing.
X
ABCC7 p.Asp979Ala 11118444:84:40
status: NEWX
ABCC7 p.Asp979Ala 11118444:84:99
status: NEW93 We separated the contributions of the R347H and D979A mutations to R347H-D979A-CFTR whole-cell Cl- current production studying both single and double mutants.
X
ABCC7 p.Asp979Ala 11118444:93:48
status: NEWX
ABCC7 p.Asp979Ala 11118444:93:73
status: NEW96 Mean changes in cAMP-activated currents recorded at 20 mV from R347H (29.4 Ϯ 12.2 pA/pF; n ϭ 8), D979A (67.9 Ϯ 18.9 pA/pF; n ϭ 5), and R347H-D979A (1.2 Ϯ 0.8 pA/pF; n ϭ 9) mutants were significantly different (p Ͻ 0.05) from wild-type (130.2 Ϯ 34.7 pA/pF; n ϭ 5), corresponding to 23, 52, and 1% of the wild-type Cl- current (Fig. 2D).
X
ABCC7 p.Asp979Ala 11118444:96:109
status: NEWX
ABCC7 p.Asp979Ala 11118444:96:165
status: NEW97 R347H, D979A, and R347H-D979A were also significantly different from each other (p Ͻ 0.01).
X
ABCC7 p.Asp979Ala 11118444:97:7
status: NEWX
ABCC7 p.Asp979Ala 11118444:97:24
status: NEW99 The decreased whole-cell Cl- cAMP-dependent current observed with D979A probably reflected CFTR protein misprocessing, although we cannot firmly exclude altered channel properties.
X
ABCC7 p.Asp979Ala 11118444:99:66
status: NEW100 Thus these data indicate that the R347H-D979A double mutant combined at least D979A misprocessing and the R347H Cl-channel defect to produce a very severe phenotype.
X
ABCC7 p.Asp979Ala 11118444:100:40
status: NEWX
ABCC7 p.Asp979Ala 11118444:100:78
status: NEW101 Charge-reversal Mutants-Taking into account the functional defects that result when Arg-347 and Asp-979 are each replaced with an uncharged amino acid such as His (uncharged at pH 7.3) and Ala (R347H and D979A), we constructed additional mutants with different charge combinations at residues 347 and 979, including the R347D-D979R double mutant in which the positive and negative charges were swapped.
X
ABCC7 p.Asp979Ala 11118444:101:204
status: NEW109 C, current-voltage (I-V) curve in HeLa cells expressing R347H (filled circle), D979A (filled triangle), and R347H-D979A (filled square) mutants.
X
ABCC7 p.Asp979Ala 11118444:109:79
status: NEWX
ABCC7 p.Asp979Ala 11118444:109:114
status: NEW121 Whole-cell measurements indicated that D979R resulted in a much greater decrease in chloride current (4.5 Ϯ 2.4 pA/pF; n ϭ 6) than D979A (Fig. 2D), although both proteins were processed similarly.
X
ABCC7 p.Asp979Ala 11118444:121:143
status: NEW123 The Cl- current of R347D-D979R (2.8 Ϯ 1.7 pA/pF; n ϭ 9) was not significantly different from those of D979R and R347H-D979A (Fig. 2D).
X
ABCC7 p.Asp979Ala 11118444:123:130
status: NEW127 Clinical data suggested that R347H and D979A, two mild CF-associated mutations, can produce severe CF similar to that of ⌬F508 homozygotes when combined in cis.
X
ABCC7 p.Asp979Ala 11118444:127:39
status: NEW129 D979A reduces the amount of CFTR protein at the cell membrane, whereas R347H generates a defective Cl-channel.
X
ABCC7 p.Asp979Ala 11118444:129:0
status: NEW130 The mutant R347H-D979A combines both defects for a dramatic decrease in Cl- current.
X
ABCC7 p.Asp979Ala 11118444:130:17
status: NEW131 The magnitude of Cl- current in vitro paralleled the severity of the disease, with D979A (congenital bilateral absence of the vas deferens) Ͼ R347H (mild CF) Ͼ R347H-D979A (severe CF).
X
ABCC7 p.Asp979Ala 11118444:131:83
status: NEWX
ABCC7 p.Asp979Ala 11118444:131:178
status: NEW136 Our data support this view, as replacing Asp-979 by Ala, Val, or Arg significantly impaired processing.
X
ABCC7 p.Asp979Ala 11118444:136:41
status: NEW143 First, several lines of experimental evidence indicate that there is probably no direct salt bridge between Arg-347 and Asp-979: (i) removal of either the positive charge at position 347 (R347H and R347D) or the negative charge at position 979 (D979A, D979V, and D979R) has different effects on CFTR processing; (ii) the double-neutral (R347H-D979A) and reversed-charged (R347D-D979R) replacements for Arg-347 and Asp-979 do not lead to the recovery of wild-type processing.
X
ABCC7 p.Asp979Ala 11118444:143:245
status: NEWX
ABCC7 p.Asp979Ala 11118444:143:343
status: NEW
No.
Sentence
Comment
181
Clain et al. investigated the complex allele with two mild mutations (R347H-D979A) previously identified in pancreatic sufficient CF patients and CBAVD patients respectively (Clain et al. 2001).
X
ABCC7 p.Asp979Ala 12940920:181:76
status: NEW182 R347H was found to be associated with moderately defective Cl-channel activity whereas D979A led to misprocessing of CFTR.
X
ABCC7 p.Asp979Ala 12940920:182:87
status: NEW183 The double mutant, R347H-D979A, combined both defects and dramatically decreased the Cl- current.
X
ABCC7 p.Asp979Ala 12940920:183:25
status: NEW
PMID: 15084988
[PubMed]
Naruse S et al: "A finger sweat chloride test for the detection of a high-risk group of chronic pancreatitis."
No.
Sentence
Comment
51
The 9 CF-causing mutations (R75X, Q98R, M152R, R347H, L441P, L571S, D979A, H1085R, and T1086I) in Japa- nese20,25-28 were screened by SNP typing with Masscode System (Shimadzu, Kyoto, Japan).
X
ABCC7 p.Asp979Ala 15084988:51:68
status: NEW
PMID: 15121783
[PubMed]
Fujiki K et al: "Genetic evidence for CFTR dysfunction in Japanese: background for chronic pancreatitis."
No.
Sentence
Comment
219
The nine CF causing (R75X, Q98R, M152R, R347H, L441P, L571S, D979A, H1085R, and T1086I) and two non-CF causing (Q1352H and R1453W) mutations in Japanese6 22-24 were screened by SNP typing with a Masscode system (Shimadzu, Kyoto, Japan) and confirmed by sequence analysis in positive and equivocal cases.
X
ABCC7 p.Asp979Ala 15121783:219:61
status: NEW
PMID: 15537723
[PubMed]
Jalalirad M et al: "First study of CF mutations in the CFTR gene of Iranian patients: detection of DeltaF508, G542X, W1282X, A120T, R117H, and R347H mutations."
No.
Sentence
Comment
32
The next two most common mutations were W1282X (4 per cent) and G542X (2.7 per cent), which have high frequencies in Mediterranean countries.11 R347H, which has the highest incidence in Turkey,8 was detected in a Turkish child residing in north-west Iran with normal sweat chloride values.
X
ABCC7 p.Asp979Ala 15537723:32:118
status: NEW33 As regards R347H mutation and sex, two female patients carrying genotypes ∆F508/R347H and ∆F508/R347H + D979A have been reported so far.12,13 Our R347H compound case is the first female who does not carry the ∆F508 mutation as the other CF allele.
X
ABCC7 p.Asp979Ala 15537723:33:118
status: NEW
PMID: 16840743
[PubMed]
Wilschanski M et al: "Mutations in the cystic fibrosis transmembrane regulator gene and in vivo transepithelial potentials."
No.
Sentence
Comment
54
CFTR GENE MUTATIONS IN THE PATIENT GROUPS Control Subjects (n ϭ 31) Heterozygotes (n ϭ 21) CBAVD-1 (n ϭ 18) CBAVD-2 (n ϭ 36) CF-PS (n ϭ 24) CF-PI (n ϭ 26) G542X*/R75Q ⌬F508*/- (n ϭ 16) ⌬F508* (n ϭ 6) ⌬F508*/2789ϩ5G→A* ⌬F508*/R117H [5T]* (n ϭ 4) ⌬F508*/⌬F508* (n ϭ 11) ⌬F508* ⌬F508*/5T W1282X*/5T (n ϭ 8) R334W*/R334W* ⌬F508*/A455E* (n ϭ 2) ⌬F508*/G542X* (n ϭ 2) G542X* W1282X*/- (n ϭ 2) D1152H† ⌬F508*/R117H [7T] (n ϭ 10) ⌬F508*/3849ϩ10kbC→T* (n ϭ 2) ⌬F508*/G551D* (n ϭ 2) R117H[7T] G85E† /R75Q L206W† ⌬F508*/R117C [7T] G551D*/3849ϩ10kbC→T* ⌬F508*/621ϩ1G→T* (n ϭ 2) S431G R75Q/- A198P G551D*/R117H [7T] ⌬F508*/3272-26A→G† (n ϭ 2) ⌬F508*/2789ϩ5 G→A* 5T ⌬F508*/5T (n ϭ 8) ⌬F508*/P574H† (n ϭ 2) ⌬F508*/W1282X* G542X*/5T ⌬F508*/I1234V† ⌬F508*/G85E* W1282X*/5T ⌬F508*/P67L† ⌬F508*/L1077P† (n ϭ 2) ⌬F508*/P67L† ⌬F508*/R347H† G551D*/G480C† ⌬F508*/L206W† ⌬F508*/5T ⌬F508*/- (n ϭ 2) ⌬F508*/M952T† ⌬F508*/875ϩ1G→C† -/- ⌬F508*/S549R† G551D*/R75Q A455E*/L206W† ⌬F508*/- (n ϭ 2) 621ϩG→T*/R117C [7T] A455E*/- R117H [7T]/5T ⌬I507*/- R117L[7T]/5T -/- R117H/R117H [7T/7T] D979A/5T 5T/-741T→G 4016insT† /D110H Definition of abbreviations: CBAVD ϭ congenital bilateral absence of the vas deferens; CF-PI ϭ pancreatic-insufficient cystic fibrosis; CF-PS ϭ pancreatic-sufficient cystic fibrosis.
X
ABCC7 p.Asp979Ala 16840743:54:1647
status: NEW
PMID: 20706124
[PubMed]
Lucarelli M et al: "A new complex allele of the CFTR gene partially explains the variable phenotype of the L997F mutation."
No.
Sentence
Comment
103
In vivo findings and, in some cases, in vitro functional characterizations have been reported for [F508C; S1251N],38 [R347H; D979A],39,40 [R74W; D1270N],41 [G628R; S1235R],42,43 [M470V; S1235R],42 [S912L; G1244V],44 [R117H; (TG)mTn],45-47 [R117C; (TG)mTn],46 [S1235R; (TG)mT5],48 [G576A; R668C],10,49 [V562I; A1006E],49 [R352W; P750L],49 [1198_1203del TGGGCT; 1204GϾA],49 [V754M; CFTRdele3_10,14b_16],50 and [F508del; I1027T].51 These complex alleles have been found in patients with either CF or CFTR-RD, although more often in the former.
X
ABCC7 p.Asp979Ala 20706124:103:125
status: NEW
PMID: 20932301
[PubMed]
Green DM et al: "Mutations that permit residual CFTR function delay acquisition of multiple respiratory pathogens in CF patients."
No.
Sentence
Comment
74
For Pa, the hazard ratio Table 1 Classification of CFTR alleles Category Mutation Specific mutations Class I Defective Protein Synthesis (nonsense, frameshift, aberrant splicing) 1078delT, 1154 insTC, 1525-2A > G, 1717-1G > A, 1898+1G > A, 2184delA, 2184 insA, 3007delG, 3120+1G > A, 3659delC, 3876delA, 3905insT, 394delTT, 4010del4, 4016insT, 4326delTC, 4374+1G > T, 441delA, 556delA, 621+1G > T, 621-1G > T, 711+1G > T, 875+1G > C, E1104X, E585X, E60X, E822X, G542X, G551D/R553X, Q493X, Q552X, Q814X, R1066C, R1162X, R553X, V520F, W1282X, Y1092X Class II Abnormal Processing and Trafficking A559T, D979A, ΔF508, ΔI507, G480C, G85E, N1303K, S549I, S549N, S549R Class III Defective Channel Regulation/Gating G1244E, G1349D, G551D, G551S, G85E, H199R, I1072T, I48T, L1077P, R560T, S1255P, S549 (R75Q) Class IV Decreased Channel Conductance A800G, D1152H, D1154G, D614G, delM1140, E822K, G314E, G576A, G622D, G85E, H620Q, I1139V, I1234V, L1335P, M1137V, P67L, R117C, R117P, R117H, R334W, R347H, R347P, R347P/ R347H, R792G, S1251N, V232D Class V Reduced Synthesis and/or Trafficking 2789+5G > A, 3120G > A, 3272-26A > G, 3849+10kbC > T, 5T variant, 621+3A > G, 711+3A > G, A445E, A455E, IVS8 poly T, P574H was increased 3 fold for those with 'Minimal` function when compared to those with 'Residual` function.
X
ABCC7 p.Asp979Ala 20932301:74:600
status: NEW
PMID: 21483833
[PubMed]
Drevillon L et al: "COMMD1-mediated ubiquitination regulates CFTR trafficking."
No.
Sentence
Comment
26
Two ICL3 mutations (S945L, D979A) are associated with the CF phenotype (Figure 1A), suggesting the importance of this region in the maturation and/or function of CFTR [16,17].
X
ABCC7 p.Asp979Ala 21483833:26:27
status: NEW70 Asterisks indicate the position of two class II mutations: S945L and D979A.
X
ABCC7 p.Asp979Ala 21483833:70:69
status: NEW111 COMMD1 regulates CFTR ubiquitination through an ICL3 motif As part of the yeast two-hybrid screen, targeted two-hybrid tests between COMMD1 and ICL3 mutants S945L and D979A were conducted.
X
ABCC7 p.Asp979Ala 21483833:111:167
status: NEW
PMID: 23060444
[PubMed]
Wang G et al: "Regulation of Activation and Processing of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) by a Complex Electrostatic Interaction between the Regulatory Domain and Cytoplasmic Loop 3."
No.
Sentence
Comment
154
Finally, D979A in CF patients causes misprocessing (33).
X
ABCC7 p.Asp979Ala 23060444:154:9
status: NEW193 Finally, D979A in CF patients causes misprocessing (33).
X
ABCC7 p.Asp979Ala 23060444:193:9
status: NEW
PMID: 9550362
[PubMed]
Hojo S et al: "Severe cystic fibrosis associated with a deltaF508/R347H + D979A compound heterozygous genotype."
No.
Sentence
Comment
7
Further testing of their CFTR gene as well as those of their Japanese mother and grandmother revealed missense mutations in exon 7 (R347H) and exon 16 (D979A).
X
ABCC7 p.Asp979Ala 9550362:7:152
status: NEW8 Although the D979A mutant is very rare, this mutation combination seemed to be responsible for severe CF phenotypes.
X
ABCC7 p.Asp979Ala 9550362:8:13
status: NEW14 - R347H and D979A Received 25 September 1997, revisedand accepted for publication28 October 1997 Following the identification of AF508 as the major mutation causing cystic fibrosis (CF), approximately 800 additional mutations, sequence variations and polymorphisms have been reported by members of the CF Genetic Analysis Consortium. ,The rare mutation R347H was first detected by Cremonesi et al. (1) in a patient with mild CF.
X
ABCC7 p.Asp979Ala 9550362:14:12
status: NEW20 In this study, we report on two women (twins) with the AF508 deletion on one CF chromosome and R347H and D979A on the other who show very severe C F phenotypes.
X
ABCC7 p.Asp979Ala 9550362:20:105
status: NEW75 The missense mutation D979A in exon 16 substitutes asparagine for an alanine residue at base position 3086 (exon 16).
X
ABCC7 p.Asp979Ala 9550362:75:22
status: NEW76 D979A mutant is very rare in Caucasian and Japanese.
X
ABCC7 p.Asp979Ala 9550362:76:0
status: NEW77 There has been no literature reporting the D979A mutation, and our analysis of 80 Japanese anonymous chromosomes for the D979A variant in non-CF patients, as well as in our other six Japanese CF patients, did not reveal any other 52 individuals who carried this allelic form.
X
ABCC7 p.Asp979Ala 9550362:77:43
status: NEWX
ABCC7 p.Asp979Ala 9550362:77:121
status: NEW79 These facts suggested that D979A mutants have a significant effect on CFTR function when combined with the R347H mutation.
X
ABCC7 p.Asp979Ala 9550362:79:27
status: NEW81 Although D979A mutant is very rare, the combination of AF508 on one chromosome and R347H +D979A on the other chromosome resulted in a severe phenotype.
X
ABCC7 p.Asp979Ala 9550362:81:9
status: NEW
PMID: 9272157
[PubMed]
Dork T et al: "Distinct spectrum of CFTR gene mutations in congenital absence of vas deferens."
No.
Sentence
Comment
84
Six other new missense mutations were located in the carboxyterminal transmembrane domain, particularly in the third cytoplasmic loop (R933S, V938G, L973F, D979A).
X
ABCC7 p.Asp979Ala 9272157:84:156
status: NEW87 This study V938G T→G at 2945 exon 15 3 D3 This study L973F T→A at 3048 and C→T at 3049 exon 16 1 D3 This study D979A A→C at 3068 exon 16 1 n.p.
X
ABCC7 p.Asp979Ala 9272157:87:132
status: NEW95 D979A and V1153E are non-conservative amino-acid changes in exons 16 and 18, respectively, at positions adjacent to other known CBAVD mutations, viz. I980K and D1152H (Bienvenu et al. 1996; W. E. Highsmith et al. personal communication).
X
ABCC7 p.Asp979Ala 9272157:95:0
status: NEW137 Complex alleles are indicated a One CF allele with R75X and 125G→C b One CBAVD allele with R75Q and R933S c One CBAVD allele with 5T and Q1352H d Two CF alleles with F508C and S1251N e One CF allele with 1716G→A and L619S f G576A and R668C were linked on two CBAVD and three CF alleles, whereas two additional CF alleles carried R668C together with the 3849+10kB C→T mutation (Dörk and Stuhrmann 1995) 371 Table 3 CFTR mutation genotypes in 106 males with CAVD Genotype PolyT Frequency Ethnic descent Diagnosis ∆F508/R117H 9/7 21 German, Austrian 20 CBAVD, 1 CUAVD ∆F508/5T 9/5 9 German, Austrian 8 CBAVD, 1 CUAVD ∆F508/F508C 9/7 3 German CBAVD ∆F508/R347H 9/9 2 German CBAVD ∆F508/1716 G→A 9/7 2 German CBAVD ∆F508/3272-26 A→G 9/7 2 German CBAVD ∆F508/E56K 9/7 1 German CBAVD ∆F508/M265R 9/7 1 German-Portuguese CBAVD ∆F508/R334W 9/9 1 German CBAVD ∆F508/T351S 9/9 1 German CBAVD ∆F508/L375F 9/7 1 Volga German CBAVD ∆F508/G576A & R668C 9/7 1 German CBAVD ∆F508/R933S 9/7 1 German CBAVD ∆F508/L997F 9/9 1 German CBAVD ∆F508/Y1032C 9/7 1 German CBAVD ∆F508/D1152H 9/7 1 German CBAVD ∆F508/K1351E 9/7 1 German CBAVD ∆F508/D1377H 9/7 1 Portuguese CBAVD ∆F508/L1388Q 9/7 1 German CBAVD ∆F508/unknown 9/7 4 German 3 CBAVD, 1 CUAVD 5T/5T 5/5 2 German CBAVD 5T/G542X 5/9 2 German, Turkish CBAVD 5T/D58N 5/7 1 Lebanese CBAVD 5T/̃L138 5/7 1 German-Polish CBAVD 5T/1078delT 5/7 1 German CBAVD 5T/R553X 5/7 1 German CBAVD 5T/2184insA 5/7 1 Turkish CBAVD 5T/D979A 5/7 1 Vietnamese CBAVD 5T/D1152H 5/7 1 Turkish CBAVD 5T/3659delC 5/7 1 German CBAVD 5T/S1235R 5/7 1 Greek CBAVD 5T/W1282X 5/7 1 German CBAVD 5T & Q1352H/ R297W & Q1352H 5/7 1 Vietnamese CBAVD 5T/unknown 5/7 1 German CBAVD R117H/L206W 7/9 1 German CBAVD R117H/2789+5 G→A 7/7 1 German CBAVD R117H/unknown 7/7 1 German CBAVD 2789+5 G→A/2789+5 G→A 7/7 1 Lebanese CBAVD 2789+5 G→A/L973F 7/7 1 German CBAVD V938G/V938G 7/7 1 Greek CBAVD V938G/174delA 7/7 1 German CBAVD D110H/D110H 7/7 1 Turkish CBAVD R334L/I336K 7/7 1 German CBAVD R347H/N1303K 9/9 1 German CBAVD L568F/D1152H 7/7 1 Turkish CBAVD 3272-26 A→G/V1153E 7/7 1 German CBAVD R75Q/unknown 7/7 1 German CBAVD A120T/unknown 9/7 1 German CBAVD 1716G→A/unknown 7/7 1 German CBAVD G576A & R668C/unknown 7/7 1 German CBAVD 2752-15 C→G/unknown 7/7 1 Iranian CBAVD Unknown/unknown 17 German, Turkish 7 CBAVD and 1 CUAVD without observed renal agenesis, 9 CBAVD with renal agenesis allele and the R297W mutation on a homozygous Q1352H background may then reduce CFTR function to a disease-causing level.
X
ABCC7 p.Asp979Ala 9272157:137:1634
status: NEW145 Maldigestion 13 25 5T/D58N 184 99 55 - 14 34 5T/̃L138 177 80 53 - 15 33 5T/1078delT 187 87 56 Recurrent bronchitis 16 31 5T/G542X 181 85 79 - 17 31 5T/2184insA n.d. n.d. 60 Borderline pancreatic sufficiency 18 31 5T/D979A n.d. n.d. 55 Recurrent infections, FEVI 76% 19 29 5T/D1152H n.d. n.d. 57 - 20 32 5T/W1282X 180 76 n.d. Recurrent infections, nasal polyposis 21 37 5T/unknown 180 74 n.d. Nasal polyposis 22 28 D110H/D110H 175 80 n.d Asthma bronchiale, obstipation 23 33 R334L/I336K 170 65 n.d. Recurrent infections, nasal polyposis, maldigestion, salt depletion episodes 24 35 N1303K/R347H 167 77 93 - 25 30 V938G/174delA n.d. n.d. 42 - 26 29 V938G/V938G 197 115 n.d. Asthma bronchiale Fig.2 Spectrum of CFTR mutation genotypes in CF patients (left) and in patients with congenital absence of the vas deferens (right).
X
ABCC7 p.Asp979Ala 9272157:145:222
status: NEW